Eurogin is part of the Informa Markets Division of Informa PLC

Informa
Informa

Preliminary Program is live!

Colposcopy Course

Wednesday, February 8, 2023 • 8.00 - 13.30

Coordinators:
J. Bornstein (Israel) • A. Singer (UK)

Welcome to the EUROGIN Colposcopy course. Taking care of cervical precancer has evolved significantly in recent years. However, the basis remains – Colposcopy. Performing colposcopy necessitates knowledge and experience. In this course, you will learn the fundamentals of the use of the colposcope and the essentials of diagnosing and treating precancerous cervical lesions.

The EUROGIN course has traditionally been led by professor Albert Singer, and we have the great pleasure of having him with us again this year, co-sharing the leadership of this course with Professor Jacob Bornstein, who headed the IFCPC Nomenclature committee that produced the contemporary colposcopy terminology.

Colposcopy is the visual examination of the epithelial cervix using either uni - or binocular vision. Specific abnormalities associated with both squamous and glandular precancer can be identified especially after the application of a 5% acetic acid solution. After this application, the abnormalities become visible as a result to changes in the epithelium and blood vessels in the stroma.

These changes occur within an area of the cervix called the transformation zone, an area bounded by the junction of the vaginal epithelium and the glandular epithelium arising from the endocervix (canal). Within this area, a change occurs in which glandular epithelium changes to squamous by a process of transformation, called metaplasia. The upper border of this metaplastic change is called the new squamocolumnar junction. The inability to see this junction means that abnormality may exist higher up in the endo cervix. A sample of any abnormality within the transformation zone can be taken by a simple punch biopsy.

Colposcopy is an essential part of the diagnosis and treatment of cervical precancer. It is indicated in the presence of abnormal cytology or in the finding of certain types of HPV and also when there are clinical symptoms and signs of early invasive cancer.

Upon completion of this educational activity, participants should be able to:

  • Describe the anatomy, cytology, histology, and colposcopic findings of the normal and abnormal cervix;
  • Define the pathophysiology of lower genital tract neoplasia, including the role of HPV in preinvasive and invasive diseases of the cervix;
  • Define the IFCPC colposcopy terminology;
  • Recognize the diagnostic characteristics of cervical abnormalities (minor-grade and major-grade cervical lesions as well as glandular lesions and cervical cancer) on the cytologic, colposcopic, and histologic examination;
  • Interpret and correlate cytologic, colposcopic, and histologic results;
  • Describe treatment options to include cryosurgery and large loop excision of the transformation zone (LLETZ)of the cervix;
  • Provide appropriate patient education and support.

8.00 - 8.15

Opening

J. Bornstein (Israel)

8.15 - 9.00

The normal cervix and the colposcopy examination

A. Singer (UK)

9.00 - 9.45

Update in pathology and cytology for colposcopists

S. Regauer (Austria)

9.45 - 10.30

Colposcopy of "abnormal" cervix, colposcopy terminology

J. Bornstein (Israel)

10.30 - 10.45

Coffee Break

10.45 - 11.30

Management protocols of abnormal screening findings and the value of biomarkers

J. Bonde (Denmark)

11.30 - 12.15

Treatment of cervical precancer and treatment's complications

J. Bornstein (Israel)

12.15 - 13.15

Interactive session (What is your diagnosis)

A. Singer (UK)

13.15 - 13.30

Course Summary

A. Singer (UK)